All In Biotech

Drug Trial Radar · NCT05882045

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease

Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,946 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,946

Actual

Start

May 30, 2023

Primary completion

Apr 16, 2026

Study completion May 14, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
May 31, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.

Conditions

  • Obesity
  • Cardiovascular Diseases

Interventions

  • RetatrutideDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Body WeightTime frame: Baseline, Week 80

Locations

169 sites in 10 countries. Site status is shown where the registry gives one.

  • Central Phoenix Medical Clinic

    Phoenix, Arizona

  • Valley Clinical Trials, Inc.

    Covina, California

  • Neuro-Pain Medical Center

    Fresno, California

  • Valley Research

    Fresno, California

  • Collaborative Neuroscience Research, LLC

    Los Alamitos, California

  • Velocity Clinical Research, Westlake

    Los Angeles, California

  • Valley Clinical Trials, Inc.

    Northridge, California

  • Velocity Clinical Research, Panorama City

    Van Nuys, California

  • Chase Medical Research, LLC

    Waterbury, Connecticut

  • Indago Research & Health Center, Inc

    Hialeah, Florida

  • Clinical Neuroscience Solutions, Inc. dba CNS Healthcare

    Jacksonville, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Charter Research - Winter Park

    Orlando, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Pacific Diabetes & Endocrine Center

    Honolulu, Hawaii

  • Elite Clinical Trials

    Blackfoot, Idaho

  • Humphreys Diabetes Center

    Boise, Idaho

  • Northwestern University

    Chicago, Illinois

  • Great Lakes Clinical Trials - Gurnee

    Gurnee, Illinois

  • Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative

    Springfield, Illinois

  • Brengle Family Medicine

    Indianapolis, Indiana

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas

  • MedVadis Research Corporation

    Waltham, Massachusetts

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • Palm Research Center Tenaya

    Las Vegas, Nevada

  • IMA Clinical Research Warren

    Warren Township, New Jersey

  • Weill Cornell Medical College

    New York, New York

  • Rochester Clinical Research, LLC

    Rochester, New York

  • Carteret Medical Group

    Morehead City, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Altoona Center For Clinical Research

    Duncansville, Pennsylvania

  • UPMC Montefiore University Hospital

    Pittsburgh, Pennsylvania

  • Tribe Clinical Research, LLC

    Greenville, South Carolina

  • Trial Management Associates

    Myrtle Beach, South Carolina

  • Tribe Clinical Research - Spartanburg

    Spartanburg, South Carolina

  • Texas Diabetes & Endocrinology, P.A.

    Austin, Texas

  • Pinnacle Clinical Research

    Austin, Texas

  • South Texas Clinical Research

    Corpus Christi, Texas

Showing 40 of 169 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.